AEterna Zentaris brings on new CEOCanada's AEterna Zentaris ($AEZS), a developer of oncology and endocrine therapies, has hired
David Dodd to the company's top position.
Dodd has been involved in the sale of Stem Cell Sciences and Serologicals Corporation ...
[Published FierceBiotech - Apr 19 2013]